Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001140361-16-046816

Director sold 11,520 shares at an average $38.79 ($446,890)

  • Director acquired 11,520 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bailey Sue · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-04 Exercise or conversion : show line 1 in the form +5,760 $11.67 $67,219 34,260 D
2016-01-04 Sale : show line 2 in the form −5,760 $38.97 $224,467 28,500 D
2016-01-04 Exercise or conversion : show line 3 in the form +2,880 $16.13 $46,454 31,380 D
2016-01-04 Sale : show line 4 in the form −2,880 $38.77 $111,658 28,500 D
2016-01-04 Exercise or conversion : show line 5 in the form +2,880 $22.02 $63,418 31,380 D
2016-01-04 Sale : show line 6 in the form −2,880 $38.46 $110,765 28,500 D
Open-market sales · 11,520 sh · avg $38.79 · $446,890

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-04 Exercise or conversion : show line 7 in the form Stock Option −5,760 $11.67 2019-05-20 5,760 2,880 D
2016-01-04 Exercise or conversion : show line 8 in the form Stock Option −2,880 $16.13 2020-05-19 2,880 2,880 D
2016-01-04 Exercise or conversion : show line 9 in the form Stock Option −2,880 $22.02 2021-05-18 2,880 4,320 D
Loading xslF345X03/doc1.xml…